TASS: 93.2 percent of adolescents developed immunity to COVID-19 after Sputnik M 
After vaccination with Sputnik M “93.2 percent of adolescents have developed cellular immunity to COVID-19. This follows from the instructions of the drug, reports TASS.
“Immunization with the drug” Gam-COVID-Vac-M “forms an antigen – a specific cellular anti-infectious immunity in 93.2 percent of the surveyed volunteers,” – says the text of the instruction.
Earlier it was reported that the vaccine is contraindicated in severe allergic reactions, infectious and non-infectious diseases. Sputnik M should be used with caution in chronic diseases of the liver, kidneys and endocrine system.
On November 24, the Gamaleya National Research Center for Epidemiology and Microbiology received registration for the COVID-19 vaccine for adolescents Sputnik M … It was created on the same platform as the Russian drug for coronavirus Sputnik V. It consists of two components, which are injected at intervals of 21 days.